`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________________________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________________________
`
`
`RIGEL PHARMACEUTICALS, INC.,
`
`Petitioner,
`
`v.
`
`SERVIER PHARMACEUTICALS LLC
`
`Patent Owner.
`
`____________________________
`
`Case IPR2022-01423
`U.S. Patent No. 10,610,125
`
`
`JOINT MOTION TO TERMINATE
`
`
`
`
`
`
`
`The Parties in this case have reached a settlement that addresses this
`
`Case IPR2022-01423
`U.S. Patent No. 10,610,125
`
`
`
`
`
`proceeding. The Parties therefore contacted the Board on December 18, 2022 to
`
`inform them of the settlement and request instructions regarding termination of this
`
`proceeding. In accordance with the Board’s email instructions received on
`
`December 19, 2022, the Parties hereby jointly submit this motion to terminate.
`
`The Parties respectfully request that the Board terminate IPR2022-01423 with
`
`prejudice.
`
`
`
`Pursuant to 35 U.S.C. § 317(b), 37 C.F.R. § 42.74, and the Board’s e-mail,
`
`the Parties have concurrently filed the Settlement Agreements as Exhibits 1059 and
`
`1060. The Parties state that there are no other agreements, oral or written, between
`
`the Parties made in connection with, or in contemplation of, the termination of the
`
`proceeding. The Parties have concurrently filed a joint request to treat the
`
`Settlement Agreements as confidential business information pursuant to 37 C.F.R.
`
`§ 42.74(c), consistent with the provisions of the Agreements.
`
`
`
`
`
`1
`
`
`
`
`Case IPR2022-01423
`U.S. Patent No. 10,610,125
`
`
`Respectfully submitted,
`
`
`By: /James L. Lovsin/
` James L. Lovsin, Reg. No. 69,550
`
`lovsin@mbhb.com
` MCDONNELL BOEHNEN
` HULBERT & BERGHOFF LLP
` 300 S. Wacker Drive
` Chicago, IL 60606
` 312-913-0001
`
`
` Counsel for Petitioner
` Rigel Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /William M. Fink/
`
` William M. Fink, Reg. No. 72,332
`
`
`tfink@omm.com
`
`
` O’MELVENY & MYERS LLP
`
`
` 1625 I Street NW
` Washington D.C. 20006
`
` (202) 383-5300
`
`
`
`
` Counsel for Patent Owner
` Servier Pharmaceuticals LLC
`
`
`Date: December 27, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`